ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,751,504 | -40.2% | 5,284,386 | -6.3% | 0.01% | -39.1% |
| Q2 2023 | $28,014,329 | -1.7% | 5,636,686 | -2.3% | 0.02% | -8.0% |
| Q1 2023 | $28,498,791 | -8.4% | 5,768,986 | +16.7% | 0.02% | -10.7% |
| Q4 2022 | $31,097,232 | -41.2% | 4,943,916 | +1.0% | 0.03% | -45.1% |
| Q3 2022 | $52,843,000 | -5.1% | 4,892,866 | +0.2% | 0.05% | +2.0% |
| Q2 2022 | $55,666,000 | +24.5% | 4,882,966 | -0.5% | 0.05% | +47.1% |
| Q1 2022 | $44,696,000 | -35.7% | 4,906,266 | +5.2% | 0.03% | -29.2% |
| Q4 2021 | $69,554,000 | -24.9% | 4,661,815 | +29.3% | 0.05% | -26.2% |
| Q3 2021 | $92,631,000 | -0.7% | 3,604,300 | +0.8% | 0.06% | +3.2% |
| Q2 2021 | $93,289,000 | +102.4% | 3,577,030 | +174.0% | 0.06% | +96.9% |
| Q1 2021 | $46,081,000 | +47.4% | 1,305,400 | +5.4% | 0.03% | +39.1% |
| Q4 2020 | $31,257,000 | – | 1,238,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
| Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
| TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
| Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
| Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
| Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
| HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
| Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
| Navalign, LLC | 64,428 | $961,000 | 0.38% |
| Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |